• 1
    Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999;341(7):461467.DOI: 10.1056/NEJM199908123410701
  • 2
    Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess (Winch) 2003;7(11):177.
  • 3
    Wright DE, Bray I. Estimating birth prevalence of Down's syndrome. J Epidemiol Biostat 2000;5(2):8997.
  • 4
    Office for National Statistics. Birth Statistics, Series FM1, Numbers 25–27, 1998 [1996, 1997, 1998].
  • 5
    Aitchison J, Dunsmore IR. Statistical Prediction Analysis Cambridge: Cambridge University Press, 1975.
  • 6
    Cuckle HS. Growing complexity in the choice of Down's syndrome screening policy. Ultrasound Obstet Gynecol 2002;19(4):323326.
  • 7
    Copel JA, Bahado-Singh RO. Prenatal screening for Down's syndrome—a search for the family's values. N Engl J Med 1999;341(7):521522.
  • 8
    Herman A, Dreazen E, Tovbin J, Weinraub Z, Bukovsky Y, Maymon R. Comparison between disclosure and non-disclosure approaches for trisomy 21 screening tests. Hum Reprod (Oxf) 2002;17(5):13581362.
  • 9
    Wright DE, Bradbury I, Benn P, Cuckle H, Ritchie K. Contingent screening for Down's syndrome is an efficient alternative to non-disclosure sequential screening. Prenatal Diagnosis. In press.